Why Teladoc Health Stock Dove 32% in November

Teladoc Health (NYSE: TDOC) shareholders lost ground to the market last month as their stock dove 32% compared to a 0.8% decline in the S&P 500. According to data from S&P Global Market Intelligence, the slump helped push shares down over 50% so far in 2021 compared to an over 22% spike in the wider market.

Teladoc had been a favorite on Wall Street during the earlier phases of the pandemic, but sentiment turned against the virtual care specialist as social distancing efforts eased. Investors sold shares off during last month's move against high-growth tech stocks, too.

Image source: Getty Images.

Source Fool.com